000963.SZ Stock Analysis
00
Neutral
Based on Eyestock quantitative analysis, 000963.SZ`s fundamental data and valuation indicate an investment grade of Neutral at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Undervalued
Market cap $B
6.788
Dividend yield
2.72 %
Shares outstanding
1 754.12 B
Huadong Medicine Co., Ltd. engages in the production and sale of antibiotics, proprietary Chinese medicine, chemical synthetic medicine, and genetic engineering drugs. The company is headquartered in Hangzhou, Zhejiang and currently employs 12,427 full-time employees. The company went IPO on 2000-01-27. The firm is mainly engaged in the research and development of pharmaceuticals, the production and sales of chemical drugs, bulk drugs and preparations of traditional Chinese medicine, the distribution and retails of pharmaceuticals, medicine modern logistics, health industry, and the manufacturing and sales of medical beauty products. The firm's products principally include Chinese patent drugs, immunosuppressive agents, endocrine drugs, digestive system drugs, antineoplastic drugs, cardiovascular drugs and antibiotic drugs. The firm distributes its products in domestic market and to overseas markets.